FIELD: medicine.
SUBSTANCE: in an intensive phase of the therapeutic course, a conventional anti-tuberculosis therapy is added with the oral preparation Thiotriazoline 100 mg 2 times a day daily for 45 days. Besides, pulmonary administration of the preparation Hixozide 350 mg dissolved in 10 ml of water for injection every second day in the number of 20 procedures is added.
EFFECT: infiltrate resolution, cavity closure and abacillation with no hepatotoxic reaction ensured by creating high concentrations of drug preparations directly in the lesion and increased activity of the immune system.
2 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2013 |
|
RU2521197C1 |
METHOD OF TREATING PATIENTS SUFFERING PULMONARY TUBERCULOSIS | 2011 |
|
RU2456006C1 |
METHOD OF TREATING PATIENTS SUFFERING PULMONARY TUBERCULOSIS | 2012 |
|
RU2491077C1 |
METHOD FOR TREATMENT OF PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2007 |
|
RU2347575C1 |
METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS | 2008 |
|
RU2380113C1 |
METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS WITH ACCOMPANYING NON-SPECIFIC BRONCHITES | 2013 |
|
RU2526121C1 |
METHOD OF TREATING PULMONARY TUBERCULOSIS | 2011 |
|
RU2452495C1 |
METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2015 |
|
RU2587332C1 |
METHOD OF TREATING PATIENTS SUFFERING PULMONARY TUBERCULOSIS | 2016 |
|
RU2621875C1 |
METHOD OF TREATING PULMONARY TUBERCULOSIS IN HIV-PATIENTS | 2008 |
|
RU2380114C1 |
Authors
Dates
2014-06-10—Published
2013-03-11—Filed